Skip to main content


  • AddRemove
  • Build a Report 
News Releases

Mayer Brown advises GW Pharmaceuticals on $206.08 million Nasdaq offering

15 May 2015
Mayer Brown represented GW Pharmaceuticals plc, a biopharmaceutical company, in a $206.08 million US public offering of American Depositary Shares on the Nasdaq Global Market led by Morgan Stanley, BofA Merrill Lynch and Cowen and Company.

The Mayer Brown team was led by Corporate & Securities partner David Bakst (New York) and included: Corporate & Securities partner Richard Smith (London) and associates George Rudy, Kelly Camp (both New York) and Vivian Chiu (London); Tax Transactions & Consulting partners Jason Bazar (New York) and James Hill (London), senior associate Benjamin Fryer (London) and associate Jared Goldberger (New York); and Intellectual Property – partner Richard Assmus and counsel Jonathan Kim (both Chicago).

The Build a Report feature requires the use of cookies to function properly.  Cookies are small text files that are placed on your computer by websites that you visit. They are widely used in order to make websites work, or work more efficiently.  If you do not accept cookies, this function will not work.  For more information please see our Privacy Policy

You have no pages selected. Please select pages to email then resubmit.